Metabolomics analysis of saliva from patients with primary Sjögren's syndrome

Clinical and Experimental Immunology

Volumn 182, Issue 2, 2015, Pages 149-153

  Kageyama, G ^a   Saegusa, J ^a   Irino, Y ^b   Tanaka, S ^a   Tsuda, K ^a   Takahashi, S ^a   Sendo, S ^a   Morinobu, A ^a  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Major salivary glanditis; Metabolomics; Saliva; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; FUCOSE; GLYCINE; RHEUMATOID FACTOR; TYROSINE; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SALIVA; SALIVARY GLAND; SIALOADENITIS; SJOEGREN SYNDROME; CHEMISTRY; METABOLISM; METABOLOME; MIDDLE AGED; PROCEDURES;

ADULT; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METABOLOME; METABOLOMICS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; SALIVA; SJOGREN'S SYNDROME;

EID: 84944173857     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12683     Document Type: Article

References (15)

1. Zhang A, Sun H, Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol 2012; 168:1718-27.
2. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxf) 2006; 45:1077-86.
3. Hu S, Wang J, Meijer J et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007; 56:3588-600.
4. Baldini C, Giusti L, Ciregia F et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren's syndrome from secondary Sjogren's syndrome and other sicca syndromes. Arthritis Res Ther 2011; 13:R194.
5. Villas-Boas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J. Mass spectrometry in metabolome analysis. Mass Spectrom Rev 2005; 24:613-46.
6. Wei J, Xie G, Zhou Z et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2011; 129:2207-17.
7. Barnes VM, Ciancio SG, Shibly O et al. Metabolomics reveals elevated macromolecular degradation in periodontal disease. J Dent Res 2011; 90:1293-7.
8. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010; 6:78-95.
9. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61:554-8.
10. Nakamizo S, Sasayama T, Shinohara M et al. GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients. J Neurooncol 2013; 113:65-74.
11. Shiboski SC, Shiboski CH, Criswell L et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64:475-87.
12. Fleissig Y, Deutsch O, Reichenberg E et al. Different proteomic protein patterns in saliva of Sjogren's syndrome patients. Oral Dis 2009; 15:61-8.
13. Delaleu N, Mydel P, Kwee I, Brun JG, Jonsson MV, Jonsson R. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren's syndrome. Arthritis Rheumatol 2015; 67:1084-95.
14. Ehrlich GE. Kelley's textbook of rheumatology, 6th edn. JAMA 2002; 287:117-18.
15. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Medicine (Balt) 2009; 88:284-93.